
Time is Running Out to Join the Healthcare Innovation Conversation at INVEST 2025
MedCity INVEST is a boutique healthcare investor conference scheduled for May 20-21 at the Willis Tower in Chicago. Register today!
MedCity INVEST is a boutique healthcare investor conference scheduled for May 20-21 at the Willis Tower in Chicago. Register today!
Sibel Health raised $30 million to accelerate the commercial deployment of its remote patient monitoring platform. The company also announced its seventh FDA clearance, which enables clinicians to use alarms and alerts along with the Sibel’s central platform.
Two hospital-at-home providers, DispatchHealth and Medically Home, announced their plan to merge. Once combined, the company will provide in-home care across 50 major metropolitan areas and partner with nearly 40 health systems.
Charity Tarn, an investor with Arboretum Ventures, will be one of the investor judges for the Pitch Perfect contest at INVEST in Chicago May 20-21. Register today!
Palantir is poised to have a significant impact on the healthcare sector, said Scott Arnold, CIO and chief of innovation at Tampa General Hospital. Partnering with the tech company has allowed Tampa General to "solve problems in hours and days instead of months and years," he remarked.
This year, venture capitalists in the digital health landscape have many more quality investment opportunities than they did in the past couple years, according to Oak HC/FT Partner Billy Deitch. He noted that many startups have been preserving the capital over the past two years with the plan to raise funds in 2025.
Memorial Sloan Kettering Cancer Center partnered with AWS to accelerate its research with AI. The collaboration seeks to speed up drug discovery and increase activity within the health system’s startup accelerator.
Atria Health launched its partnership model for cardiology practices nationwide this week. Instead of buying and then subsequently owning practices, Atria provides capital, expertise and technology to help cardiologists build independent, physician-led practices.
The healthcare investor conference, scheduled for May 20 and 21 at the Willis Tower in Chicago, combines panel discussions, networking opportunities, and a startup pitch contest. Register today!
The Anthos Therapeutics acquisition represents a homecoming for its drug abelacimab, which originated in Novartis’s labs. The antibody offers the potential to prevent blood clots without the bleeding risks associated with currently available anticoagulants.
Dan Liljenquist, Intermountain Health’s chief strategy officer, said that more large health systems should employ a hub-and-spoke model to ensure that rural providers can thrive. Under this model, large health systems partner with rural hospitals — with the rural “spoke” hospitals gaining access to the larger “hub” health system’s technology, staff, medication discounts and more.
Infectious disease is the focus of the biopharma track at INVEST Pitch Perfect May 20-21 in Chicago. Register today!
Through a new partnership, members of Christian Healthcare Ministries can pick one doctor on HealthTap’s platform for ongoing primary care. They can also access on-demand virtual urgent care.
The structure of Atalanta Therapeutics’ RNA interference drugs enables them to distribute broadly and deeply into brain tissue. Lead programs for Huntington’s disease and a rare inherited form epilepsy are on track to enter the clinic this year.
As companies begin to make plans for 2025, add the INVEST Pitch Perfect Contest to your calendar.